3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Melanoma
2
Advanced Malignant Solid Neoplasm
2
Urinary Bladder Neoplasms
1
Spondylitis, Ankylosing
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Lymphedema
1
Lupus Erythematosus, Systemic
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Inflammatory Bowel Diseases
1
Hematologic Neoplasms
1
Endometrial Neoplasms
1
Crohn Disease
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Renal Cell
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthritis, Reactive
1
Arthritis, Psoriatic
1
Interventions
fludarabine
10
Specimen Handling
8
Cytarabine
8
Cyclophosphamide
8
Biopsy
8
fludarabine phosphate
7
Whole-Body Irradiation
7
venetoclax
6
Injections
6
Busulfan
6
Azacitidine
6
Mycophenolic Acid
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
decitabine and cedazuridine drug combination
4
X-Rays
4
Tacrolimus
4
Stem Cell Transplantation
4
Cyclosporine
4
CPX-351
4
Peripheral Blood Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
Idarubicin
3
Decitabine
3
treosulfan
2
ruxolitinib
2
luspatercept
2
ivosidenib
2
gilteritinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Early Intervention, Educational
×
30 days
×
Clear all
No trials found.